Abstract
Siah ubiquitin ligases play important roles in a number of signaling pathways involved in the progression and spread of cancer in cell-based models, but their role in tumor progression remains controversial. Siah proteins have been described to be both oncogenic and tumor suppressive in a variety of patient cohort studies and animal cancer models. This review collates the current knowledge of Siah in cancer progression and identifies potential methods of translation of these findings into the clinic. Furthermore, key experiments needed to close the gaps in our understanding of the role Siah proteins play in tumor progression are suggested.
©2013 AACR.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Disease Models, Animal
-
Humans
-
Molecular Targeted Therapy
-
Neoplasms / genetics
-
Neoplasms / metabolism*
-
Neoplasms / therapy
-
Nuclear Proteins / antagonists & inhibitors
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism*
-
Oncogene Proteins / genetics
-
Oncogene Proteins / metabolism
-
Tumor Suppressor Proteins / genetics
-
Tumor Suppressor Proteins / metabolism
-
Ubiquitin-Protein Ligases / antagonists & inhibitors
-
Ubiquitin-Protein Ligases / genetics
-
Ubiquitin-Protein Ligases / metabolism*
Substances
-
Nuclear Proteins
-
Oncogene Proteins
-
Tumor Suppressor Proteins
-
Ubiquitin-Protein Ligases
-
seven in absentia proteins